APIM
Agate Pass Investment Management Portfolio holdings
AUM
$244M
This Quarter Return
-2.12%
1 Year Return
+16.21%
3 Year Return
+53.11%
5 Year Return
–
10 Year Return
–
AUM
$148M
AUM Growth
+$148M
(-10%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-8.08%
Top 10 Holdings %
Top 10 Hldgs %
42.89%
Holding
93
New
–
Increased
15
Reduced
51
Closed
9
Top Buys
| 1 |
Oracle
ORCL
|
$788K |
| 2 |
Novo Nordisk
NVO
|
$602K |
| 3 |
Copart
CPRT
|
$545K |
| 4 |
Vanguard Growth ETF
VUG
|
$290K |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
$134K |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$3.54M |
| 2 |
Fiserv
FI
|
$3.29M |
| 3 |
Leggett & Platt
LEG
|
$1.59M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
$628K |
| 5 |
Parker-Hannifin
PH
|
$592K |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 15.4% |
| 3 | Financials | 7.62% |
| 4 | Consumer Discretionary | 5.42% |
| 5 | Communication Services | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Motley Fool Global Opportunities ETF
TMFG
$396M
| $262K | 0.18% |
10,028
| – | – |
|
77
American Tower
AMT
$93.9B
| $262K | 0.18% |
1,591
-352
| -18% | -$57.9K |
|
78
Bristol-Myers Squibb
BMY
$96.5B
| $244K | 0.17% |
4,200
-524
| -11% | -$30.4K |
|
79
Sherwin-Williams
SHW
$90B
| $242K | 0.16% |
947
| – | – |
|
80
Crown Holdings
CCK
$11.5B
| $241K | 0.16% |
2,729
| – | – |
|
81
iShares Core S&P Total US Stock Market ETF
ITOT
$74.6B
| $241K | 0.16% |
2,557
| – | – |
|
82
Ball Corp
BALL
$13.9B
| $213K | 0.14% |
4,278
| – | – |
|
83
CVS Health
CVS
$94B
| $209K | 0.14% |
2,999
| – | – |
|
84
W.W. Grainger
GWW
$48.6B
| $208K | 0.14% |
300
| – | – |
|
85
Blackrock
BLK
$173B
| – | – |
-368
| Closed | -$254K |
|
|
86
Fiserv
FI
$74.4B
| – | – |
-26,042
| Closed | -$3.29M |
|
87
Home Depot
HD
$404B
| – | – |
-660
| Closed | -$205K |
|
|
88
Johnson & Johnson
JNJ
$429B
| – | – |
-21,365
| Closed | -$3.54M |
|
|
89
Leggett & Platt
LEG
$1.26B
| – | – |
-53,621
| Closed | -$1.59M |
|
|
90
Parker-Hannifin
PH
$95B
| – | – |
-1,517
| Closed | -$592K |
|
91
ResMed
RMD
$39.7B
| – | – |
-1,086
| Closed | -$237K |
|
92
AT&T
T
$208B
| – | – |
-23,917
| Closed | -$381K |
|
|
ENZ
93
DELISTED
Enzo Biochem, Inc.
ENZ
| – | – |
-16,292
| Closed | -$30K |
|